Por: ABC News Health November 03, 2022
NEW YORK -- New York will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic, the largest amount secured from an opioid manufacturer or distributor sued by the state, Attorney General Letitia James announced Thursday.The state has reached a series of settlements with drug companies following an attorney general's lawsuit in 2019 accusing them of deceptive marketing and... + full article
CNN USA Business November 03, 2022
New York CNN Business — The New York Attorney General’s office announced it has secured $523 million from Teva Pharmaceuticals and affiliates for its role in the opioid crisis, effectively marking the end of the state’s litigation against opioid manufacturers and... + más
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement | Forbes
Adderall Shortage Expected to Continue for Months in the U.S. | Time
Forbes USA Business November 03, 2022
Topline Teva Pharmaceuticals will shell out as much as much as $523 million in New York to settle claims that the company contributed to the opioid crisis that has killed nearly half a million Americans, part of a $4.2 billion national settlement for the company. April Mach, a... + más
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis | ABC News
New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis | CNN
WPLG Local 10 USA Health November 03, 2022
NEW YORK – New York will receive up to $524 million from drugmaker Teva to settle claims that the company contributed to the U.S. opioid epidemic, the largest amount secured from an opioid manufacturer or distributor sued by the state, Attorney General Letitia James announced... + más
New York could get $524M under opioid settlements with Teva | ABC News
ABC News USA Health November 03, 2022
Teva Pharmaceuticals agreed Thursday to pay $523 million to settle claims stemming from the company’s role in the It’s the largest settlement New York has reached with an individual opioid defendant and raises the total amount secured from opioid manufacturers and... + más
The Boston Globe USA Nation November 03, 2022
The last remaining defendants in a once-sprawling opioid trial in New York settled Thursday, agreeing to pay over half a billion dollars for their role in fueling the opioid crisis, the state attorney general announced.The trial, which initially took on every facet of the supply... + más
Time USA Health October 14, 2022
Teva Pharmaceutical Industries Ltd.’s shortage of Adderall is expected to last through March, longer than the two to three months the company , according to U.S. regulators. The popular treatment for attention-deficit/hyperactivity disorder has been in short supply since at... + más
Did COVID-19 pandemic contribute to Adderall shortage? | ABC News
Did COVID-19 pandemic contribute to Adderall shortage? | ABC7
ABC News USA Health September 21, 2022
CHARLESTON, W.Va. -- Walmart and CVS Pharmacy have settled with the state of West Virginia for a combined total of $147 million in a lawsuit over the companies' roles in contributing to the oversupply of prescription drugs that fueled the opioid epidemic in the... + más
Baton Rouge rejects settlement in 2015 death involving stun guns: 'ripping off a Band-Aid' | The Advocate
Bob Dean nursing home settlement in limbo; Morris Bart ‘willing to call his bluff’ | The Advocate
About iurex | Privacy Policy | Disclaimer |